JP2024513958A5 - - Google Patents
Info
- Publication number
- JP2024513958A5 JP2024513958A5 JP2023562568A JP2023562568A JP2024513958A5 JP 2024513958 A5 JP2024513958 A5 JP 2024513958A5 JP 2023562568 A JP2023562568 A JP 2023562568A JP 2023562568 A JP2023562568 A JP 2023562568A JP 2024513958 A5 JP2024513958 A5 JP 2024513958A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163172423P | 2021-04-08 | 2021-04-08 | |
| US63/172,423 | 2021-04-08 | ||
| US202163290361P | 2021-12-16 | 2021-12-16 | |
| US63/290,361 | 2021-12-16 | ||
| PCT/US2022/023691 WO2022216837A1 (en) | 2021-04-08 | 2022-04-06 | Treatment of cancer with nk cells and an egfr targeted antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024513958A JP2024513958A (ja) | 2024-03-27 |
| JPWO2022216837A5 JPWO2022216837A5 (https=) | 2025-04-14 |
| JP2024513958A5 true JP2024513958A5 (https=) | 2025-04-14 |
Family
ID=83546563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562568A Pending JP2024513958A (ja) | 2021-04-08 | 2022-04-06 | Ｎｋ細胞およびｅｇｆｒ標的抗体を用いた癌治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240366664A1 (https=) |
| EP (1) | EP4319772A4 (https=) |
| JP (1) | JP2024513958A (https=) |
| KR (1) | KR20240024049A (https=) |
| CN (1) | CN118103048A (https=) |
| AU (1) | AU2022253889A1 (https=) |
| WO (1) | WO2022216837A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018124766A2 (ko) | 2016-12-28 | 2018-07-05 | 주식회사 녹십자랩셀 | 키메라 항원 수용체 및 이를 발현하는 자연 살해 세포 |
| EP3633029A4 (en) | 2017-05-26 | 2021-06-09 | Green Cross Lab Cell Corporation | METHOD OF DEVELOPING A NATURAL KILLER CELL USING A T-CELL |
| US12116417B2 (en) | 2017-11-14 | 2024-10-15 | GC Cell Corporation | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same |
| US11649294B2 (en) | 2017-11-14 | 2023-05-16 | GC Cell Corporation | Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same |
| MY199770A (en) | 2018-11-14 | 2023-11-22 | Green Cross Lab Cell Corp | Method for culturing cord blood-derived natural killer cells using transformed t cells |
| KR20240131924A (ko) * | 2023-02-24 | 2024-09-02 | 주식회사 엔케이맥스 | 항-EGFR 항체의약품과 병용하는 자연살해세포의 TKIs 내성 비소세포폐암 치료방법 |
| AU2024244976A1 (en) * | 2023-03-24 | 2025-09-25 | Board Of Regents, The University Of Texas System | Engineered natural killer cells with enhanced antitumor memory responses |
| WO2025191137A1 (en) * | 2024-03-15 | 2025-09-18 | Avidicure Ip B.V. | Conjugates of trop2-specific antigen binding proteins and cytokines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018124766A2 (ko) * | 2016-12-28 | 2018-07-05 | 주식회사 녹십자랩셀 | 키메라 항원 수용체 및 이를 발현하는 자연 살해 세포 |
| WO2019179390A1 (en) * | 2018-03-19 | 2019-09-26 | Wuxi Biologics (Shanghai) Co., Ltd. | Novel bispecific pd-1/egfr antibody molecules |
| EP4474391A3 (en) * | 2018-05-14 | 2025-02-26 | Indapta Therapeutics, Inc. | Subsets of human natural killer cells with enhanced antibody-directed immune responses |
-
2022
- 2022-04-06 JP JP2023562568A patent/JP2024513958A/ja active Pending
- 2022-04-06 KR KR1020237038629A patent/KR20240024049A/ko not_active Withdrawn
- 2022-04-06 US US18/285,648 patent/US20240366664A1/en active Pending
- 2022-04-06 CN CN202280041522.9A patent/CN118103048A/zh active Pending
- 2022-04-06 WO PCT/US2022/023691 patent/WO2022216837A1/en not_active Ceased
- 2022-04-06 EP EP22785379.3A patent/EP4319772A4/en active Pending
- 2022-04-06 AU AU2022253889A patent/AU2022253889A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023089054A5 (https=) | ||
| JP2024513958A5 (https=) | ||
| JP2024515169A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2025004171A1 (es) | Proceso para la fabricación de elementos protectores para celdas de electrolisis de agua alcalina | |
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR102022023461A2 (https=) | ||
| BY24013C1 (https=) | ||
| BY13172U (https=) | ||
| CN307046159S (https=) | ||
| CN307045528S (https=) | ||
| CN307045445S (https=) | ||
| CN307045425S (https=) | ||
| CN307044833S (https=) | ||
| CN307044766S (https=) | ||
| CN307044670S (https=) | ||
| CN307044514S (https=) | ||
| CN307044336S (https=) | ||
| BY13160U (https=) | ||
| CN307044189S (https=) | ||
| CN307047193S (https=) | ||
| BY13161U (https=) | ||
| CN307047724S (https=) |